This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via ISI Web of Science (46) Citing Articles via Google Scholar Google Scholar Articles by Sola, S. Articles by Khan, B. V. Search for Related Content PubMed PubMed Citation Articles by Sola, S. Articles by Khan, B. V.

Atorvastatin Improves Left Ventricular Systolic Function and Serum Markers of Inflammation in Nonischemic Heart Failure

Srikanth Sola, MD^_*, Muhammad Q.S. Mir, MD^_*, Stamatios Lerakis, MD, FACC, Neeraj Tandon, MD, FACC and Bobby V. Khan, MD, PhD^_*,_*

^_* Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia
Division of Cardiology, Louisiana State University Health Sciences Center, Shreveport, Louisiana.

View larger version (19K): [in a new window]   Figure 1 Change in ejection fraction in the placebo and atorvastatin groups during the 12-month study follow up. *p = 0.01 for the difference in ejection fraction between baseline and 6 or 12 months within the atorvastatin group; p = 0.04 for the difference in ejection fraction between baseline and 12 months within the placebo group; p = 0.004 for the difference in ejection fraction at 12 months between the placebo and the atorvastatin groups.